Monoamine oxidase inhibitors (MAO Inhibitors) are medications used to manage and treat depression, among other neurological and psychiatric illnesses. It is in the Antidepressants class of drugs. This activity reviews the indications, action, and contraindications of the commonly prescribed MAO Inhibitors as a valuable agent in managing depression and other neuropsychiatric disorders. This activity will highlight the mechanism of action, adverse event profile, and other key factors such as off-label use, administration, and relevant molecular interactions pertinent for the interprofessional team members involved in the care of patients with depression and related conditions.

**Objectives:**
- Review the mechanism of action of MAOIs.
- Identify the indications for prescribing MAOIs in clinical practice.
- Summarize the contraindications and potential side effects associated with MAOIs.
- Outline the importance of effective communication amongst the healthcare team members in delivering quality, complication-free management to the patients under their care.